Literature DB >> 9356804

Iron, infections, and anemia of inflammation.

R L Jurado1.   

Abstract

Iron is essential to all microorganisms. To obtain iron from the very low concentrations present in their environment, microorganisms have developed sophisticated mechanisms such as the siderophore system. As a primitive defense mechanism, humans have developed mechanisms to withhold iron from microorganisms. Iron-binding proteins such as transferrin, ferritin, and lactoferrin have a central role in human ferrokinetics. These iron-binding proteins also participate in the process of decreasing iron availability for the microorganisms. They do so by decreasing iron reutilization. Anemia of inflammation (previously called anemia of chronic disease) is seen in the setting of infectious, inflammatory, and neoplastic diseases. It results, in part, from changes in the intracellular metabolism of iron. Alterations of iron physiology seen in many clinical circumstances make excess iron available to microorganisms, thus enhancing their pathogenicity. Understanding the molecular basis of iron withholding by the human host, both in the absence of and during infection, and that of iron acquisition by microorganisms may provide us with new and innovative antimicrobial agents and vaccines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9356804     DOI: 10.1086/515549

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  79 in total

1.  β-Carotene can reverse dysregulation of iron protein in an in vitro model of inflammation.

Authors:  Oksana Katz; Ram Reifen; Aaron Lerner
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

Review 2.  Mammalian antibiotic peptides.

Authors:  P Síma; I Trebichavský; K Sigler
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

3.  Chemical scaffolds with structural similarities to siderophores of nonribosomal peptide-polyketide origin as novel antimicrobials against Mycobacterium tuberculosis and Yersinia pestis.

Authors:  Julian A Ferreras; Akash Gupta; Neal D Amin; Arijit Basu; Barij N Sinha; Stefan Worgall; Venkatesan Jayaprakash; Luis E N Quadri
Journal:  Bioorg Med Chem Lett       Date:  2011-08-26       Impact factor: 2.823

4.  Iron acquisition from transferrin by Candida albicans depends on the reductive pathway.

Authors:  Simon A B Knight; Gaston Vilaire; Emmanuel Lesuisse; Andrew Dancis
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 5.  Recent advances in intestinal iron transport.

Authors:  Gregory J Anderson; David M Frazer
Journal:  Curr Gastroenterol Rep       Date:  2005-10

6.  Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA).

Authors:  Michael J Wagner; Rahul Mitra; Mark J McArthur; Wallace Baze; Kirstin Barnhart; Sherry Y Wu; Cristian Rodriguez-Aguayo; Xinna Zhang; Robert L Coleman; Gabriel Lopez-Berestein; Anil K Sood
Journal:  Mol Cancer Ther       Date:  2017-03-06       Impact factor: 6.261

7.  Transfusion of older stored blood worsens outcomes in canines depending on the presence and severity of pneumonia.

Authors:  Dong Wang; Irene Cortés-Puch; Junfeng Sun; Steven B Solomon; Tamir Kanias; Kenneth E Remy; Jing Feng; Meghna Alimchandani; Martha Quezado; Christine Helms; Andreas Perlegas; Mark T Gladwin; Daniel B Kim-Shapiro; Harvey G Klein; Charles Natanson
Journal:  Transfusion       Date:  2014-03-03       Impact factor: 3.157

8.  KCa(H2 O)2 [FeIII (CN)6 ]⋅H2 O Nanoparticles as an Antimicrobial Agent against Staphylococcus aureus.

Authors:  Zhongxia Wang; Bing Yu; Huda Alamri; Sriramakrishna Yarabarla; Min-Ho Kim; Songping D Huang
Journal:  Angew Chem Int Ed Engl       Date:  2018-02-02       Impact factor: 15.336

9.  Basal endocrine status in African dietary iron overload.

Authors:  Lynette McNamara; Vanessa R Panz; Frederick J Raal; Janice Paiker; Barry I Joffe; Victor R Gordeuk; A Patrick MacPhail
Journal:  Endocrine       Date:  2003-08       Impact factor: 3.633

10.  A case of severe pyruvate kinase deficiency in a primigravida: successful outcome.

Authors:  Sahar Mohamed; Kenga Sivarajah; Seema Chakravarti
Journal:  Obstet Med       Date:  2013-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.